MyeloPro was established in December 2015 in Vienna, Austria.

We are located at the Muthgasse 11/2, 1190 Vienna.

Our research focus is on developing therapeutics to treat myeloproliferative neoplasms.

We are currently in the discovery/hit-to-lead transition stage of research.